Press Release, see on the net as: http://www.prweb.com/releases/2003/9/prweb78916.htm
Sunnyvale, CA – September 5th, 2003 -- HelixoMetry, inc. announces “The Genome Duality Principle” by its Founder, CEO and inventor of FractoGene (Utility Patent submitted).
Technology: Biotechnology
HelixoMetry announces the core patenting phase of FractoGene has been accomplished. The inventor now turns both to Academia and to Industry to put forward “The Genome Duality Principle”, promulgated here. The Principle attributes to coding- and non-coding DNA a mutually supportive role in which neither is inferior to the other, thereby changing Genomics from a “fishing expedition for fewer and fewer genes” into an Information Challenge: decipher the genetic code in which both “coding” and “non-coding” DNA play essential parts. The Principle is similar to von Neumann’s architecture of computers where zeros and ones could either represent programs or data. The scholarly notion of The Genome Duality Principle is that the fractal coding in the DNA of fractal organisms (neurons, lungs, etc.) is novel, non-obvious, and it lends itself to a broad array of applications in Biotech, Nanotech and Infotech. That principle was preceded by patenting FractoGene (as a Provisional Application in July 31st, 2002 and as a final Utility Application on July 28th, 2003 by Dr. Pellionisz).
Sunnyvale, CA –(PRWEB) September 5th, 2003 -- HelixoMetry, Inc. http://helixometry.com announces that biophysicist Dr. András J. Pellionisz, Founder, CEO and inventor of “FractoGene” (Utility Patent Pending, http://fractogene.com) formally established “The Genome Duality Principle” – a radical paradigm-shift for the second 50 years of the “Genome Revolution”. The scientific axiom will be published in the Special Issue of “The Cerebellum” (publisher Taylor & Francis, invited editor A. Pellionisz, http://fractogene.com/cerebellum/index.html) and will be presented on the Nanotechnology World Conference in an invited lecture by Dr. Pellionisz (October, 2003, Orlando, FL, http://usa-siliconvalley.com/inst/pellionisz/), see Keynote Address to the 204th World Conference of the EEC in Orlando, FL
“Dualism and symmetry are profound characteristics of Nature, from matter and anti-matter, to covariant and contravariant (dual) representations of sensory and motor expressions”, says Pellionisz, who won the prestigious Alexander von Humboldt Prize for Distinguished American Scientists from Germany for his pioneering Tensor Network Theory of neural nets earlier. “Von Neumann and Eugene Wigner, two of my fellow-countrymen spearheaded science pursuing the concept of dual representation in Nature. Dualism has always been a striking feature of the Double Helix itself, ever since its discovery 50 years ago” - he continues.
"Is the 'Genome Duality Principle' a mere hypothesis or is confirmed by irrefutable evidence?" - we ask. "It is surprising that the 'theory' of 'junk DNA' has not yet been killed by hard evidence. For example, Friedreich's spinocerebellar ataxia is firmly established, as a deadly disease not caused by an exon, but by its first intron, an example of so-called 'junk DNA'. If it is 'just junk,' then it could not cause such a disease, one that is similar to Huntington's of Alzheimer's (etc), which are caused by exon triplet runs. In science, facts don't kill theories, only a better theory kills an inferior conjecture. FractoGene as a mathematical explanation of 'junk DNA' will, in turn, relegate the notion of 'junk DNA to oblivion." - he says.
It was at the exclusive Genome Revolution meeting, the 50th Anniversary Celebration of the Double Helix in Monterey, February 2003, http://fractogene.com/thefutureoflife/, that Dr. Pellionisz first voiced the idea that the concept of “junk DNA” may be a cardinal fallacy of the Genome Revolution. He pointed out the striking parallel of zeros and ones in computer memory that either represent programs (like exons in the DNA) or data (like introns in the DNA) is a direct parallel with von Neumann’s cardinal contribution to the architecture of modern computers. There was practically nobody in the audience (that included James Watson, Francis Collins, Craig Venter and the like) who would believe that “junk DNA” was, indeed, “just junk”. However, what was lacking at that time was a mathematical blueprint (fractals) describing the encryption of DNA, with the exons (in humans, a mere 1.3% of the DNA) spelling out the protein-coding of fractal templates, while the vast majority (in humans, 98.7% of the DNA) providing the “fractal improvements”.
“You had to endure a lot of flak for your ‘patent first, publish later’ policy of our time” – we asked Dr. Pellionisz. “Indeed, but as a sign of our times I don’t take it personally. Especially since I did publish close to 120 books, chapters and scholarly articles on my mathematical explanation of the “little brain” (the cerebellum). Understanding a good part of the brain had a substantial impact on Philosophy (spawning “Neurophilosopyhy” http://usa-siliconvalley.com/inst/pellionisz/85_churchland/85_churchland.html) and resulted in pilot projects at NASA to fly an F15 by an artificial cerebellum http://usa-siliconvalley.com/inst/pellionisz/f15neuralnet.html – but these achievements were largely intellectual, without much socio-economic impact. This time, however, the stakes for Big Pharma, Big Information Technology and Nanotechnology are just far too immense to put forward massive investments without adequate protection of assets on a major scale. With FractoGene Provisional patent application filed by July 31st, 2002, and the FractoGene Utility Patent application that followed well within the deadline of July 31st, 2003, the time is right now to “publish” - once the patent applications are filed”.
“Is that also true when seeking funds for rapid development?” – we asked. “Not necessarily” – Pellionisz responds. “There is already a landslide of turning to ‘non-coding DNA’ – just look at the August issue of Bio-IT Word:http://www.bioitworld.com/archive/081303/horizons_aussie.html , where Kevin Davies, Francis Collins, Charles Cantor and Kate Murashige discuss the explosive issue of “non-coding DNA” and its early (that is, *non*-fractal) patents. FractoGene stands alone in providing a mathematical design-utility for protein-based biotech, nanotech and infotech. The interest is sufficient for a closely held enterprise. There is an immense amount of investment to create the shells of “Biopolis” and “Silicon Valley” type infrastructure all over the World, even in New Europe, and "Big Information Technology" (on the scale of IBM, Oracle are clearly and openly committed). HelixoMetry is positioning with FractoGene to make the most intelligent move, going with the best offer. After all, all infrastructure is empty shell without the creative minds for the next 50 years of the Genome Revolution.”
Contact information:
Dr. Andras J. Pellionisz
Founder and CEO of HelixoMetry, Inc.
Inventor of FractoGene (Patent Pending)
Tel: 408.732.9319
Cell:408.891.7187
Fax: 408.746.2765
Cob@helixometry.com
http://helixometry.com
http://fractogene.com